Technology describes a unique profile of microRNAs from the mir-200 family and mir-10a can identify and distinguish survivors of abnormal lung development and congential diaphragmatic hernia after prenatal tracheal occlusion. Technology also includes normalizing miR-200b expression before birth in a.....
[更多]
These biomarkers offer three benefits which are key to clinical and commercial success:1. Multiple applications - Novel, proprietary biomarkers for diagnosis, prognosis and monitoring of CRC 2. Stand-alone or multiplexed - The biomarkers can potentially be used in stand-alone assays, or as part of m.....
[更多]
| |< <- | [6505] [6506] [6507] [6508] [6509] [6510] [6511] [6512] [6513] [6514] [6515] | -> >| |
